A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Top Cited Papers
- 21 February 2002
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 346 (8), 564-569
- https://doi.org/10.1056/nejmoa01133202
Abstract
A monoclonal gammopathy of undetermined significance (MGUS) occurs in up to 2 percent of persons 50 years of age or older. Reliable predictors of progression have not been identified, and information on prognosis is limited.Keywords
This publication has 13 references indexed in Scilit:
- The Threat to Medical-Records ResearchThe New England Journal of Medicine, 1997
- History of the Rochester Epidemiology ProjectMayo Clinic Proceedings, 1996
- Malignant transformation of monoclonal gammopathy of undetermined significance among out‐patients of a community hospital in Southeastern NetherlandsBritish Journal of Haematology, 1995
- Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1992
- Monoclonal gammopathies in the adult population of Finistere, France.Journal of Clinical Pathology, 1982
- Monoclonal gammopathy of undetermined significance: Natural history in 241 casesThe American Journal of Medicine, 1978
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966
- Frequency of “Abnormal” Serum Globulins (M‐Components) in the AgedActa Medica Scandinavica, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958